BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19161758)

  • 1. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Eriksson HI; Jalonen JR; Heikkinen LO; Kivikko M; Laine M; Leino KA; Kuitunen AH; Kuttila KT; Peräkylä TK; Sarapohja T; Suojaranta-Ylinen RT; Valtonen M; Salmenperä MT
    Ann Thorac Surg; 2009 Feb; 87(2):448-54. PubMed ID: 19161758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative levosimendan in ischemic mitral valve repair.
    Sharma P; Malhotra A; Gandhi S; Garg P; Bishnoi A; Gandhi H
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):539-45. PubMed ID: 24867027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
    Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
    Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
    Anastasiadis K; Antonitsis P; Vranis K; Kleontas A; Asteriou C; Grosomanidis V; Tossios P; Argiriadou H
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):740-747. PubMed ID: 27378790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
    Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
    Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
    Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
    PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
    Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients.
    Atalay H; Temizturk Z; Altinsoy HB; Azboy D; Colak S; Atalay A; Dogan OF
    Heart Surg Forum; 2016 Oct; 19(5):E230-E236. PubMed ID: 27801303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic preoperative levosimendan for off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: Single-centered randomized prospective study.
    Desai PM; Sarkar MS; Umbarkar SR
    Ann Card Anaesth; 2018; 21(2):123-128. PubMed ID: 29652271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.
    Lomivorotov VV; Cherniavskiy AM; Boboshko VA; Kornilov IA; Lomivorotov VN; Karaskov AM
    Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):154-9. PubMed ID: 21471262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study.
    Shah B; Sharma P; Brahmbhatt A; Shah R; Rathod B; Shastri N; Patel J; Malhotra A
    Indian J Pharmacol; 2014; 46(1):29-34. PubMed ID: 24550581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: double-blind randomized placebo-controlled trial.
    Husedzinović I; Barisin S; Bradić N; Barisin A; Sonicki Z; Milanović R
    Croat Med J; 2005 Dec; 46(6):950-6. PubMed ID: 16342349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
    J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
    Lahtinen P; Pitkänen O; Pölönen P; Turpeinen A; Kiviniemi V; Uusaro A
    Crit Care Med; 2011 Oct; 39(10):2263-70. PubMed ID: 21666445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of coronary artery bypass grafting in patients with left ventricular dysfunction.
    Soliman Hamad MA; Tan ME; van Straten AH; van Zundert AA; Schönberger JP
    Ann Thorac Surg; 2008 Feb; 85(2):488-93. PubMed ID: 18222250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
    Tritapepe L; De Santis V; Vitale D; Guarracino F; Pellegrini F; Pietropaoli P; Singer M
    Br J Anaesth; 2009 Feb; 102(2):198-204. PubMed ID: 19151048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative intraaortic balloon pumping improves outcomes for high-risk patients in routine coronary artery bypass graft surgery.
    Santarpino G; Onorati F; Rubino AS; Abdalla K; Caroleo S; Santangelo E; Renzulli A
    Ann Thorac Surg; 2009 Feb; 87(2):481-8. PubMed ID: 19161764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).
    Caruba T; Hourton D; Sabatier B; Rousseau D; Tibi A; Hoffart-Jourdain C; Souag A; Freitas N; Yjjou M; Almeida C; Gomes N; Aucouturier P; Djadi-Prat J; Menasché P; Chatellier G; Cholley B
    J Cardiothorac Surg; 2016 Aug; 11(1):127. PubMed ID: 27496105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.